Consistent with the findings of the present study, previous researches have confirmed that XRCC4 overexpression in uterine cervical cancer [10], esophageal cancer [12] and hepatocellular carcinoma [13]. This evidence concerns the gene XRCC4 and hepatocellular carcinoma.